T&L Co. Ltd (340570) - Net Assets

Latest as of September 2025: ₩199.09 Billion KRW ≈ $134.92 Million USD

Based on the latest financial reports, T&L Co. Ltd (340570) has net assets worth ₩199.09 Billion KRW (≈ $134.92 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩219.17 Billion ≈ $148.53 Million USD) and total liabilities (₩20.08 Billion ≈ $13.61 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check T&L Co. Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets ₩199.09 Billion
% of Total Assets 90.84%
Annual Growth Rate 32.62%
5-Year Change 138.27%
10-Year Change N/A
Growth Volatility 33.36

T&L Co. Ltd - Net Assets Trend (2017–2024)

This chart illustrates how T&L Co. Ltd's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of T&L Co. Ltd for the complete picture of this company's asset base.

Annual Net Assets for T&L Co. Ltd (2017–2024)

The table below shows the annual net assets of T&L Co. Ltd from 2017 to 2024. For live valuation and market cap data, see 340570 market cap overview.

Year Net Assets Change
2024-12-31 ₩171.44 Billion
≈ $116.18 Million
+32.33%
2023-12-31 ₩129.55 Billion
≈ $87.80 Million
+22.14%
2022-12-31 ₩106.07 Billion
≈ $71.88 Million
+17.74%
2021-12-31 ₩90.09 Billion
≈ $61.05 Million
+25.21%
2020-12-31 ₩71.95 Billion
≈ $48.76 Million
+116.52%
2019-12-31 ₩33.23 Billion
≈ $22.52 Million
+22.00%
2018-12-31 ₩27.24 Billion
≈ $18.46 Million
+14.64%
2017-12-31 ₩23.76 Billion
≈ $16.10 Million
--

Equity Component Analysis

This analysis shows how different components contribute to T&L Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 565.4% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Retained Earnings ₩140.26 Billion 81.82%
Common Stock ₩4.46 Billion 2.60%
Other Components ₩26.71 Billion 15.58%
Total Equity ₩171.44 Billion 100.00%

T&L Co. Ltd Competitors by Market Cap

The table below lists competitors of T&L Co. Ltd ranked by their market capitalization.

Company Market Cap
Sarana Meditama Metropolitan
JK:SAME
$333.92 Million
Samudera Indonesia Tbk
JK:SMDR
$333.92 Million
Ratchthani Leasing Public Company Limited
BK:THANI
$333.96 Million
Mount Gibson Iron Ltd
AU:MGX
$334.09 Million
Regional Management Corp
NYSE:RM
$333.82 Million
Omni Bridgeway Ltd
AU:OBL
$333.58 Million
Lifezone Metals Limited
NYSE:LZM
$333.46 Million
Jumbo Interactive Ltd
AU:JIN
$333.38 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in T&L Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 129,553,114,070 to 171,436,202,680, a change of 41,883,088,610 (32.3%).
  • Net income of 46,407,511,870 contributed positively to equity growth.
  • Dividend payments of 4,439,606,050 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income ₩46.41 Billion +27.07%
Dividends Paid ₩4.44 Billion -2.59%
Other Changes ₩-84.82 Million -0.05%
Total Change ₩- 32.33%

Book Value vs Market Value Analysis

This analysis compares T&L Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 2.88x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 16.48x to 2.88x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 ₩3712.52 ₩61200.00 x
2018-12-31 ₩4255.98 ₩61200.00 x
2019-12-31 ₩5192.39 ₩61200.00 x
2020-12-31 ₩8852.28 ₩61200.00 x
2021-12-31 ₩11083.81 ₩61200.00 x
2022-12-31 ₩13140.77 ₩61200.00 x
2023-12-31 ₩16049.67 ₩61200.00 x
2024-12-31 ₩21238.35 ₩61200.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently T&L Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 27.07%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 26.54%
  • • Asset Turnover: 0.89x
  • • Equity Multiplier: 1.15x
  • Recent ROE (27.07%) is above the historical average (20.39%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2017 20.21% 18.06% 0.79x 1.41x ₩2.43 Billion
2018 17.10% 17.69% 0.72x 1.34x ₩1.93 Billion
2019 21.93% 22.34% 0.75x 1.30x ₩3.96 Billion
2020 13.96% 24.71% 0.51x 1.10x ₩2.85 Billion
2021 21.74% 27.24% 0.73x 1.09x ₩10.58 Billion
2022 19.91% 25.89% 0.70x 1.10x ₩10.51 Billion
2023 21.18% 23.76% 0.81x 1.10x ₩14.48 Billion
2024 27.07% 26.54% 0.89x 1.15x ₩29.26 Billion

Industry Comparison

This section compares T&L Co. Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $103,716,724,510
  • Average return on equity (ROE) among peers: -3.52%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
T&L Co. Ltd (340570) ₩199.09 Billion 20.21% 0.10x $333.87 Million
Shinhung (004080) $77.28 Billion 1.29% 0.82x $88.63 Million
HansBiomed Corporation (042520) $33.89 Billion -92.49% 2.73x $258.75 Million
JVM Co. Ltd (054950) $104.90 Billion 4.97% 0.55x $195.14 Million
Huvitz Co. Ltd (065510) $78.68 Billion 3.95% 0.79x $58.02 Million
Vieworks Co. Ltd (100120) $126.17 Billion 15.56% 0.09x $165.07 Million
Corentec Co Ltd (104540) $60.18 Billion 0.77% 0.59x $50.52 Million
Humasis Co. Ltd (205470) $346.73 Billion 52.67% 0.35x $61.42 Million
NH SPAC 2 (206640) $151.09 Billion 29.36% 0.27x $169.86 Million
Hana Must SPAC 2 (208370) $26.92 Billion -55.25% 0.69x $75.64 Million
DRTECH Corporation (214680) $31.33 Billion 3.98% 0.59x $98.45 Million

About T&L Co. Ltd

KQ:340570 Korea Medical Devices
Market Cap
$333.87 Million
₩492.67 Billion KRW
Market Cap Rank
#14513 Global
#511 in Korea
Share Price
₩61200.00
Change (1 day)
-3.01%
52-Week Range
₩43550.00 - ₩74200.00
All Time High
₩84000.00
About

T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more